Advertisement

Topics

Pay Day For Reata As Bardoxolone Progresses For Kidney Disease In Japan

07:29 EDT 31 Aug 2018 | SCRIP

Reata reaps benefit from 2009 licensing deal with Kyowa Hakko Kirin for bardoxolone as transcription factor activator moves into pivotal...

      

Related Stories

 

Original Article: Pay Day For Reata As Bardoxolone Progresses For Kidney Disease In Japan

NEXT ARTICLE

More From BioPortfolio on "Pay Day For Reata As Bardoxolone Progresses For Kidney Disease In Japan"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...